Behavioral Coaching for Heart Attack
(HHH-2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Sixty adults who have experienced acute coronary syndrome within the past 2-12 months from three states (Rhode Island, North Carolina, Minnesota) will be randomized to either (1) a coaching program for depressed mood and health behavior change (Behavioral Activation for Health and Depression; BA-HD), or (2) Enhanced Usual Care. This study will evaluate the feasibility and acceptability of study procedures and BA-HD, and establish protocol and measurement harmonization across three sites in preparation for a future multi-site efficacy trial.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does mention that participants should be willing to make changes to their medication adherence if needed.
Is Behavioral Activation safe for humans?
How is the treatment Behavioral Activation for Health and Depression (BA-HD) different from other treatments for heart attack recovery?
Behavioral Activation for Health and Depression (BA-HD) is unique because it combines strategies to improve mood and change health behaviors, specifically targeting both depression and heart health after a heart attack. This integrated approach is different from traditional treatments that may focus solely on physical recovery or mental health separately.12346
What data supports the effectiveness of the treatment Behavioral Activation for Health and Depression (BA-HD) for heart attack patients?
Behavioral Activation (BA) has been shown to be effective in treating depression by helping people engage in activities that improve their mood and motivation. While the research specifically on heart attack patients is not provided, the techniques used in BA, such as activity scheduling and skills training, have been supported as effective components in improving mental health, which could be beneficial for heart attack recovery.13478
Who Is on the Research Team?
Andrew Busch, PhD
Principal Investigator
Hennepin Healthcare Research Institute
Emily Gathright, PhD
Principal Investigator
The Miriam Hospital
Are You a Good Fit for This Trial?
This trial is for adults who've had an acute coronary syndrome event in the last 2-12 months. It's available in Rhode Island, North Carolina, and Minnesota. Participants should be willing to undergo a coaching program or receive enhanced usual care.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomly assigned to either 12 weeks of tele-delivered BA-HD or Enhanced Usual Care
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Behavioral Activation for Health and Depression (BA-HD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Miriam Hospital
Lead Sponsor